| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4￠/kg + 52% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.52 | | Malonylurea (Barbituric acid) and its salts: | | | | |
| 2933.52.10 | 00 | Malonylurea (barbituric acid) | kg | Free | | 25% |
| 2933.53.00 | 00 | Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof | kg | Free | | 50% |
| 2933.54.00 | 00 | Other derivatives of malonylurea (barbituric acid); salts thereof | kg | 3.7% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P, SG) | 50% |
| 2933.55.00 | 00 | Loprazolam (INN), mecloqualone (INN), methaqualone (INN) and zipeprol (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.59.10 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.21 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.21 | 00 | Antihistamines, including those principally used as anti-nauseants | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 82% |
| 2933.59.22 | 00 | Nicarbazin; and Trimethoprim | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.59.70 | 00 | Aromatic or modified aromatic: | | | | |
| 2933.59.85 | 00 | 2-Amino-4-chloro-6-methoxypyrimidine; 2-Amino-4,6-dimethoxypyrimidine; and 6-Methyluracil | kg | Free | | 30.5% |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.61.00 | 00 | Melamine | kg | 3.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
| 2933.69.20 | 00 | 2,4-Diamino-6-phenyl-1,3,5-triazine | kg | Free | | 25% |
| 2933.69.60 | 15 | Sodium dichloroisocyanurate and trichloroisocyanuric acid | kg | | | |
| 2933.71.00 | 00 | Lactams: | | | | |
| 2933.71.00 | 00 | 6-Hexanelactam (ε-Caprolactam) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 2.7% (SG) | 15.4￠/kg + 40% |
